» Articles » PMID: 29785776

The Glasgow Prognostic Score at Diagnosis is an Independent Predictor of Survival in Advanced Stage Classical Hodgkin Lymphoma

Overview
Journal Br J Haematol
Specialty Hematology
Date 2018 May 23
PMID 29785776
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y Front Oncol. 2023; 12:1080729.

PMID: 36741711 PMC: 9895374. DOI: 10.3389/fonc.2022.1080729.


The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic (GEP-NEN) System.

Gebauer N, Ziehm M, Gebauer J, Riecke A, Meyhofer S, Kulemann B Cancers (Basel). 2022; 14(21).

PMID: 36358883 PMC: 9656405. DOI: 10.3390/cancers14215465.


Prognostic Factors for Clinical Outcomes in Patients with Newly Diagnosed Advanced-stage Hodgkin Lymphoma: A Nationwide Retrospective Study.

Teng C, Tan T, Pan Y, Lin Y, Lien P, Chou H Cancer Control. 2022; 29:10732748221124865.

PMID: 36134681 PMC: 9511302. DOI: 10.1177/10732748221124865.


Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies.

Gebauer N, Mengler B, Kopelke S, Frydrychowicz A, Furschke A, Hackenbroch C J Cancer Res Clin Oncol. 2021; 148(7):1789-1801.

PMID: 34415426 PMC: 9189087. DOI: 10.1007/s00432-021-03758-5.


Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with and and/or Rearrangements.

Olschewski V, Witte H, Bernard V, Steinestel K, Peter W, Merz H Cancers (Basel). 2021; 13(4).

PMID: 33672644 PMC: 7924187. DOI: 10.3390/cancers13040887.